Patents by Inventor Clifford Steer

Clifford Steer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220267367
    Abstract: Methods of preventing or retarding or reversing or abolishing the onset of Parkinson's and other neurodegenerative diseases are discussed.
    Type: Application
    Filed: March 24, 2022
    Publication date: August 25, 2022
    Inventors: Walter Low, Clifford Steer, Michael D. Finch, Cyrus B. Munshi
  • Publication number: 20210122780
    Abstract: Methods of preventing or retarding or reversing or abolishing the onset of Parkinson's and other neurodegenerative diseases are discussed.
    Type: Application
    Filed: March 29, 2019
    Publication date: April 29, 2021
    Inventors: Walter Low, Clifford Steer, Michael D. Finch, Cyrus B. Munshi
  • Patent number: 10144758
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the bile acids such as ursodeoxycholic acid (UDCA) and tauroursodeoxycholic acid (TUDCA), and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium. Also disclosed are pharmaceutical compositions and methods of using the deuterated bile acids.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: December 4, 2018
    Assignee: Metselex, Inc.
    Inventors: Michael D Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia M. P. Rodrigues, Susana Dias Lucas de Oliveira
  • Publication number: 20180030084
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Application
    Filed: July 17, 2017
    Publication date: February 1, 2018
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia M.P. Rodrigues, Susana Dias Lucas de Oliveira
  • Patent number: 9708362
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: July 18, 2017
    Assignee: Metselex, Inc.
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia Rodrigues, Susana Dias Lucas de Oliveria
  • Patent number: 9632075
    Abstract: Methods of reducing or abolishing neuropathic pain in humans and animals are discussed. In some examples administration of the apoptosis inhibitor tauroursodeoxycholic acid (TUDCA), greatly reduced both neuronal loss and the increase in glia, and partially reversed spinal nerve ligation (SNL)-induced mechanical hypersensitivity. Among RVM neurons, serotonergic (5-HT) neurons decreased by 35% ipsilateral to SNL. In some examples, the density of 5-HT immunoreactive varicosities in the superficial dorsal horn of the spinal cord was lower ipsilateral to SNL. The RVM 5-HT neurons that remained after SNL appeared to facilitate nociception. When rats that had undergone SNL were treated with the 5-HT neurotoxin, 5,7-dihydroxytryptamine (5,7-DHT), mechanical withdrawal thresholds increased significantly. In some examples nerve injury induces death of antinociceptive RVM neurons which can be reduced or abolished by TUDCA.
    Type: Grant
    Filed: November 1, 2012
    Date of Patent: April 25, 2017
    Assignee: Meselex, Inc.
    Inventors: Mai Lan Leong, Clifford Steer, Martin Wessendorf
  • Publication number: 20160168189
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Application
    Filed: February 24, 2016
    Publication date: June 16, 2016
    Applicant: Metselex, Inc.
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia Rodrigues, Susana Dias Lucas de Oliveria
  • Publication number: 20160051567
    Abstract: A method of treating or preventing kidney injury includes administering to a patient an effective amount of bile acid, a salt thereof, an analog thereof, or a combination thereof. Methods of preventing or retarding, reversing or abolishing the onset of kidney injuries are discussed. This is achieved through the administration of a bile acid, a salt of the bile acid, an analog of the bile acid or any combinations of these compounds. The bile acid abolishes or interferes or down-regulates metabolic pathways leading to the onset of kidney injury. The bile acid also activates metabolic pathways leading to the slowing or reversing or complete abolishment of the progression of acute kidney injury.
    Type: Application
    Filed: March 27, 2014
    Publication date: February 25, 2016
    Applicant: Metselex, Inc.
    Inventors: Clifford STEER, Sandeep GUPTA
  • Publication number: 20150112089
    Abstract: This disclosure relates to deuterated bile acid compositions. A deuterated compound is selected from the disclosed groups of bile acids and their derivatives, analogs and salts. At least one of the hydrogen atoms in the compound is replaced with deuterium.
    Type: Application
    Filed: October 22, 2014
    Publication date: April 23, 2015
    Applicant: Metselex, Inc.
    Inventors: Michael D. Finch, Walter Low, Clifford Steer, Cyrus B. Munshi, Cecilia Rodrigues, Susana Dias Lucas de Oliveira
  • Publication number: 20140296194
    Abstract: Methods of reducing or abolishing neuropathic pain in humans and animals are discussed. In some examples administration of the apoptosis inhibitor taurours-odeoxycholic acid (TUDCA), greatly reduced both neuronal loss and the increase in glia, and partially reversed spinal nerve ligation (SNL)-induced mechanical hypersensitivity. Among RVM neurons, serotonergic (5-HT) neurons decreased by 35% ipsilateral to SNL. In some examples, the density of 5-HT immunoreactive varicosities in the superficial dorsal horn of the spinal cord was lower ipsilateral to SNL. The RVM 5-HT neurons that remained after SNL appeared to facilitate nociception. When rats that had undergone SNL were treated with the 5-HT neurotoxin, 5,7-dihydroxytryptamine (5,7-DHT), mechanical withdrawal thresholds increased significantly. In some examples nerve injury induces death of antinociceptive RVM neurons which can be reduced or abolished by TUDCA.
    Type: Application
    Filed: November 1, 2012
    Publication date: October 2, 2014
    Inventors: Mai Lan Leong, Clifford Steer, Martin Wessendorf
  • Publication number: 20060204481
    Abstract: Methods for promoting viability of a transplant cell population by administering a hydrophilic bile acid, such as ursodeoxycholic acid (UDCA), salts thereof, and analogs thereof (e.g., glycoursodeoxycholic acid and tauroursodeoxycholic acid).
    Type: Application
    Filed: April 2, 2003
    Publication date: September 14, 2006
    Inventor: Clifford Steer
  • Publication number: 20060135494
    Abstract: Methods for treating injuries of the nervous system associated with hermorrhage by administering a hydrophilic bile acid, such as ursodeoxycholic acid (UDCA), salts thereof, and analogs thereof (e.g., glyco-, tauro-ursodeoxycholic acid, and other conjugated derivative).
    Type: Application
    Filed: October 8, 2003
    Publication date: June 22, 2006
    Inventors: Clifford Steer, Walter Low, Cecilia Rodrigues, Zhenhong Nan